PATENT CLAIM ANALYSIS

Application Number: 15873568
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["546", "268400"]

Abstract:
Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state: Also provided are processes of manufacture and methods of using the crystalline forms.

Claim (Index 108):
The method of  claim 98 , wherein the disease is alcoholic hepatitis.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.34375
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15481365', '14757585', '14757663', '15680024', '15413154']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8700137307718241
- 35 USC 102 Novelty (BERT): 0.5941104914982173
- Combined Prediction Score: 0.8424234068444635
- Mean Citation Score: 563.072668
- Max Citation Score: 681.5881
- Similarity Product: 421.37137586361166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test